Annual Cash & Cash Equivalents
$10.94 B
+$3.31 B+43.45%
31 December 2023
Summary:
Amgen annual cash & cash equivalents is currently $10.94 billion, with the most recent change of +$3.31 billion (+43.45%) on 31 December 2023. During the last 3 years, it has risen by +$4.68 billion (+74.66%). AMGN annual cash & cash equivalents is now at all-time high.AMGN Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$9.01 B
-$290.00 M-3.12%
30 September 2024
Summary:
Amgen quarterly cash and cash equivalents is currently $9.01 billion, with the most recent change of -$290.00 million (-3.12%) on 30 September 2024. Over the past year, it has dropped by -$25.73 billion (-74.06%). AMGN quarterly cash and cash equivalents is now -74.06% below its all-time high of $34.74 billion, reached on 30 September 2023.AMGN Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AMGN Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +43.5% | -74.1% |
| 3 y3 years | +74.7% | -24.7% |
| 5 y5 years | +57.6% | -21.1% |
AMGN Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +74.7% | -74.1% | +73.2% |
| 5 y | 5 years | at high | +81.3% | -74.1% | +73.2% |
| alltime | all time | at high | >+9999.0% | -74.1% | >+9999.0% |
Amgen Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $9.01 B(-3.1%) |
| June 2024 | - | $9.30 B(-4.2%) |
| Mar 2024 | - | $9.71 B(-11.3%) |
| Dec 2023 | $10.94 B(+43.5%) | $10.94 B(-68.5%) |
| Sept 2023 | - | $34.74 B(+1.4%) |
| June 2023 | - | $34.25 B(+8.5%) |
| Mar 2023 | - | $31.56 B(+313.7%) |
| Dec 2022 | $7.63 B(-4.5%) | $7.63 B(-19.7%) |
| Sept 2022 | - | $9.50 B(+82.6%) |
| June 2022 | - | $5.20 B(-20.3%) |
| Mar 2022 | - | $6.53 B(-18.3%) |
| Dec 2021 | $7.99 B(+27.5%) | $7.99 B(-33.3%) |
| Sept 2021 | - | $11.97 B(+80.5%) |
| June 2021 | - | $6.63 B(+8.5%) |
| Mar 2021 | - | $6.11 B(-2.5%) |
| Dec 2020 | $6.27 B(+3.8%) | $6.27 B(-31.0%) |
| Sept 2020 | - | $9.09 B(-0.6%) |
| June 2020 | - | $9.14 B(+19.0%) |
| Mar 2020 | - | $7.69 B(+27.3%) |
| Dec 2019 | $6.04 B(-13.1%) | $6.04 B(-47.1%) |
| Sept 2019 | - | $11.41 B(+106.6%) |
| June 2019 | - | $5.53 B(-24.9%) |
| Mar 2019 | - | $7.36 B(+5.9%) |
| Dec 2018 | $6.95 B(+82.8%) | $6.95 B(-41.9%) |
| Sept 2018 | - | $11.96 B(+18.0%) |
| June 2018 | - | $10.13 B(+4.0%) |
| Mar 2018 | - | $9.74 B(+156.3%) |
| Dec 2017 | $3.80 B(+17.2%) | $3.80 B(+26.7%) |
| Sept 2017 | - | $3.00 B(+14.1%) |
| June 2017 | - | $2.63 B(-21.7%) |
| Mar 2017 | - | $3.36 B(+3.6%) |
| Dec 2016 | $3.24 B(-21.8%) | $3.24 B(-7.0%) |
| Sept 2016 | - | $3.48 B(+32.5%) |
| June 2016 | - | $2.63 B(-9.2%) |
| Mar 2016 | - | $2.90 B(-30.1%) |
| Dec 2015 | $4.14 B(+11.1%) | $4.14 B(+28.5%) |
| Sept 2015 | - | $3.23 B(-15.0%) |
| June 2015 | - | $3.79 B(+32.5%) |
| Mar 2015 | - | $2.86 B(-23.2%) |
| Dec 2014 | $3.73 B(-1.9%) | $3.73 B(+1.5%) |
| Sept 2014 | - | $3.68 B(-15.5%) |
| June 2014 | - | $4.35 B(+18.0%) |
| Mar 2014 | - | $3.69 B(-3.1%) |
| Dec 2013 | $3.81 B(+16.8%) | $3.81 B(-54.1%) |
| Sept 2013 | - | $8.28 B(+42.6%) |
| June 2013 | - | $5.81 B(+129.5%) |
| Mar 2013 | - | $2.53 B(-22.3%) |
| Dec 2012 | $3.26 B(-53.1%) | $3.26 B(-44.1%) |
| Sept 2012 | - | $5.82 B(-0.4%) |
| June 2012 | - | $5.85 B(+39.0%) |
| Mar 2012 | - | $4.21 B(-39.4%) |
| Dec 2011 | $6.95 B(+111.3%) | $6.95 B(+78.5%) |
| Sept 2011 | - | $3.89 B(-35.1%) |
| June 2011 | - | $6.00 B(+373.8%) |
| Mar 2011 | - | $1.27 B(-61.5%) |
| Dec 2010 | $3.29 B(+14.0%) | $3.29 B(+92.0%) |
| June 2010 | - | $1.71 B(-24.4%) |
| Mar 2010 | - | $2.27 B(-21.4%) |
| Dec 2009 | $2.88 B(+62.6%) | $2.88 B(-19.4%) |
| Sept 2009 | - | $3.58 B(+20.5%) |
| June 2009 | - | $2.97 B(+6.9%) |
| Mar 2009 | - | $2.78 B(+56.5%) |
| Dec 2008 | $1.77 B(-12.4%) | $1.77 B(-29.7%) |
| Sept 2008 | - | $2.52 B(-25.6%) |
| June 2008 | - | $3.39 B(-21.6%) |
| Mar 2008 | - | $4.32 B(+113.6%) |
| Dec 2007 | $2.02 B(+57.8%) | $2.02 B(+45.7%) |
| Sept 2007 | - | $1.39 B(-19.6%) |
| June 2007 | - | $1.73 B(+61.9%) |
| Mar 2007 | - | $1.07 B(-16.8%) |
| Dec 2006 | $1.28 B(-30.3%) | $1.28 B(-0.6%) |
| Sept 2006 | - | $1.29 B(-33.7%) |
| June 2006 | - | $1.95 B(+11.4%) |
| Mar 2006 | - | $1.75 B(-5.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2005 | $1.84 B(+20.6%) | $1.84 B(-14.5%) |
| Sept 2005 | - | $2.15 B(+32.7%) |
| June 2005 | - | $1.62 B(+37.0%) |
| Mar 2005 | - | $1.18 B(-22.5%) |
| Dec 2004 | $1.53 B(+82.3%) | $1.53 B(+54.8%) |
| Sept 2004 | - | $986.00 M(-42.6%) |
| June 2004 | - | $1.72 B(+125.5%) |
| Mar 2004 | - | $761.50 M(-9.0%) |
| Dec 2003 | $837.00 M(-54.8%) | $837.00 M(-20.3%) |
| Sept 2003 | - | $1.05 B(-1.9%) |
| June 2003 | - | $1.07 B(-54.3%) |
| Mar 2003 | - | $2.34 B(+26.4%) |
| Dec 2002 | $1.85 B(+168.8%) | $1.85 B(+59.8%) |
| Sept 2002 | - | $1.16 B(-60.1%) |
| June 2002 | - | $2.90 B(-2.6%) |
| Mar 2002 | - | $2.98 B(+332.6%) |
| Dec 2001 | $689.10 M(+204.2%) | $689.10 M(+142.6%) |
| Sept 2001 | - | $284.00 M(+0.5%) |
| June 2001 | - | $282.50 M(-41.0%) |
| Mar 2001 | - | $478.90 M(+111.4%) |
| Dec 2000 | $226.50 M(+73.0%) | $226.50 M(+41.7%) |
| Sept 2000 | - | $159.80 M(+17.3%) |
| June 2000 | - | $136.20 M(+8.3%) |
| Mar 2000 | - | $125.80 M(-3.9%) |
| Dec 1999 | $130.90 M(-34.9%) | $130.90 M(-30.5%) |
| Sept 1999 | - | $188.30 M(-5.7%) |
| June 1999 | - | $199.60 M(+74.9%) |
| Mar 1999 | - | $114.10 M(-43.3%) |
| Dec 1998 | $201.10 M(-15.9%) | $201.10 M(+93.2%) |
| Sept 1998 | - | $104.10 M(-34.1%) |
| June 1998 | - | $158.00 M(+51.1%) |
| Mar 1998 | - | $104.60 M(-56.3%) |
| Dec 1997 | $239.10 M(+41.2%) | $239.10 M(-0.3%) |
| Sept 1997 | - | $239.90 M(-27.5%) |
| June 1997 | - | $331.00 M(+25.0%) |
| Mar 1997 | - | $264.80 M(+56.4%) |
| Dec 1996 | $169.30 M(+153.8%) | $169.30 M(-25.4%) |
| Sept 1996 | - | $227.00 M(+6.0%) |
| June 1996 | - | $214.20 M(+243.3%) |
| Mar 1996 | - | $62.40 M(-6.4%) |
| Dec 1995 | $66.70 M(-68.4%) | $66.70 M(-54.0%) |
| Sept 1995 | - | $145.00 M(-25.6%) |
| June 1995 | - | $194.90 M(-2.1%) |
| Mar 1995 | - | $199.00 M(-5.8%) |
| Dec 1994 | $211.30 M(+64.4%) | $211.30 M(-29.9%) |
| Sept 1994 | - | $301.50 M(+19.8%) |
| June 1994 | - | $251.60 M(+70.3%) |
| Mar 1994 | - | $147.70 M(+14.9%) |
| Dec 1993 | $128.50 M(+39.7%) | $128.50 M(-21.2%) |
| Sept 1993 | - | $163.00 M(+19.6%) |
| June 1993 | - | $136.30 M(+519.5%) |
| Mar 1993 | - | $22.00 M(-76.1%) |
| Dec 1992 | $92.00 M(-37.2%) | $92.00 M(+43.8%) |
| Sept 1992 | - | $64.00 M(-12.1%) |
| June 1992 | - | $72.80 M(-48.0%) |
| Mar 1992 | - | $140.10 M(-4.4%) |
| Dec 1991 | $146.50 M(+310.4%) | $146.50 M(+36.8%) |
| Sept 1991 | - | $107.10 M(+37.8%) |
| June 1991 | - | $77.70 M(+117.6%) |
| Mar 1991 | - | $35.70 M(-35.3%) |
| Mar 1991 | $35.70 M(-8.9%) | - |
| Dec 1990 | - | $55.20 M(+30.5%) |
| Sept 1990 | - | $42.30 M(-48.2%) |
| June 1990 | - | $81.70 M(+108.4%) |
| Mar 1990 | $39.20 M(+89.4%) | $39.20 M(+69.0%) |
| Dec 1989 | - | $23.20 M(+75.8%) |
| Sept 1989 | - | $13.20 M(-82.8%) |
| June 1989 | - | $76.80 M(+271.0%) |
| Mar 1989 | $20.70 M(-80.4%) | $20.70 M(-80.4%) |
| Mar 1988 | $105.60 M(+83.3%) | $105.60 M(+83.3%) |
| Mar 1987 | $57.60 M(-13.5%) | $57.60 M(-13.5%) |
| Mar 1986 | $66.60 M(+198.7%) | $66.60 M(+198.7%) |
| Mar 1985 | $22.30 M(-40.7%) | $22.30 M(-40.7%) |
| Mar 1984 | $37.60 M | $37.60 M |
FAQ
- What is Amgen annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Amgen?
- What is Amgen annual cash & cash equivalents year-on-year change?
- What is Amgen quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Amgen?
- What is Amgen quarterly cash and cash equivalents year-on-year change?
What is Amgen annual cash & cash equivalents?
The current annual cash & cash equivalents of AMGN is $10.94 B
What is the all time high annual cash & cash equivalents for Amgen?
Amgen all-time high annual cash & cash equivalents is $10.94 B
What is Amgen annual cash & cash equivalents year-on-year change?
Over the past year, AMGN annual cash & cash equivalents has changed by +$3.31 B (+43.45%)
What is Amgen quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of AMGN is $9.01 B
What is the all time high quarterly cash and cash equivalents for Amgen?
Amgen all-time high quarterly cash and cash equivalents is $34.74 B
What is Amgen quarterly cash and cash equivalents year-on-year change?
Over the past year, AMGN quarterly cash and cash equivalents has changed by -$25.73 B (-74.06%)